Evidence map›Paper›PMID 30218492›Full record

ArticleChemical biology & drug design2019

Biophysical screening methods for extracellular domain peptide receptors, application to natriuretic peptide receptor C ligands.

Daniel Conole, Samuel H Myers, Filipa Mota, Adrian J Hobbs, David L Selwood

Open access · hybridAbstract read
In one paragraph

Article in Chemical biology & drug design, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Daniel ConoleWolfson Institute for Biomedical Research, University College London, London, UK.ORCID 0000-0002-3389-8377
Samuel H MyersWolfson Institute for Biomedical Research, University College London, London, UK.
Filipa MotaWolfson Institute for Biomedical Research, University College London, London, UK.
Adrian J HobbsWilliam Harvey Research Institute, Heart Centre, Barts & The London School of Medicine, Queen Mary University of London, London, UK.
David L SelwoodWolfson Institute for Biomedical Research, University College London, London, UK.
Wolfson Foundation · GBQueen Mary University of London · GB

Funding

British Heart Foundation TG/15/3/31692Wellcome Trust 078496/Z/05/ZWellcome Trust 084449/Z/07/Z
6 · The paper itself

Abstract

Endothelium-derived C-type natriuretic peptide possesses cytoprotective and anti-atherogenic functions that regulate vascular homeostasis. The vasoprotective effects of C-type natriuretic peptide are somewhat mediated by the natriuretic peptide receptor C, suggesting that this receptor represents a novel therapeutic target for the treatment of cardiovascular diseases. In order to facilitate our drug discovery efforts, we have optimized an array of biophysical methods including surface plasmon resonance, fluorescence polarization and thermal shift assays to aid in the design, assessment and characterization of small molecule agonist interactions with natriuretic peptide receptors. Assay conditions are investigated to explore the feasibility and dynamic range of each method, and peptide-based agonists and antagonists are used as controls to validate these conditions. Once established, each technique was compared and contrasted with respect to their drug discovery utility. We foresee that such techniques will facilitate the discovery and development of potential therapeutic agents for NPR-C and other large extracellular domain membrane receptors.

Indexed as

Amino Acid SequenceBiophysical PhenomenaLigandsNatriuretic Peptide, C-TypeReceptors, PeptideLigandsNatriuretic Peptide, C-TypeReceptors, PeptidebiophysicalCNPfluorescence polarizationNPR-Csurface plasmon resonancethermal shift

Identifiers

PMID30218492
PMCPMC6879014
OpenAlexW2891301532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.